WO1999061052A3 - Oral immunization with papillomavirus virus-like particles - Google Patents
Oral immunization with papillomavirus virus-like particles Download PDFInfo
- Publication number
- WO1999061052A3 WO1999061052A3 PCT/US1999/011731 US9911731W WO9961052A3 WO 1999061052 A3 WO1999061052 A3 WO 1999061052A3 US 9911731 W US9911731 W US 9911731W WO 9961052 A3 WO9961052 A3 WO 9961052A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- papillomavirus
- hpv
- type
- virus
- particles
- Prior art date
Links
- 241001631646 Papillomaviridae Species 0.000 title abstract 7
- 239000002245 particle Substances 0.000 title abstract 6
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 241001428582 Human papillomavirus type 6 Species 0.000 abstract 3
- 108090000565 Capsid Proteins Proteins 0.000 abstract 2
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 101710121996 Hexon protein p72 Proteins 0.000 abstract 1
- 241000341655 Human papillomavirus type 16 Species 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241000701447 unidentified baculovirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/802—Virus-based particle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2329136 CA2329136A1 (en) | 1998-05-29 | 1999-05-27 | Oral immunization with papillomavirus virus-like particles |
JP2000550511A JP2002516291A (en) | 1998-05-29 | 1999-05-27 | Oral immunization with papillomavirus virus-like particles |
EP19990953290 EP1079858A2 (en) | 1998-05-29 | 1999-05-27 | Oral immunization with papillomavirus virus-like particles |
AU43162/99A AU4316299A (en) | 1998-05-29 | 1999-05-27 | Oral immunization with papillomavirus virus-like particles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/087,312 | 1998-05-29 | ||
US09/087,312 US6153201A (en) | 1993-03-09 | 1998-05-29 | Oral immunization with papillomavirus virus-like particles |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999061052A2 WO1999061052A2 (en) | 1999-12-02 |
WO1999061052A3 true WO1999061052A3 (en) | 2000-02-03 |
WO1999061052A9 WO1999061052A9 (en) | 2000-06-15 |
Family
ID=22204420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/011731 WO1999061052A2 (en) | 1998-05-29 | 1999-05-27 | Oral immunization with papillomavirus virus-like particles |
Country Status (6)
Country | Link |
---|---|
US (1) | US6153201A (en) |
EP (1) | EP1079858A2 (en) |
JP (1) | JP2002516291A (en) |
AU (1) | AU4316299A (en) |
CA (1) | CA2329136A1 (en) |
WO (1) | WO1999061052A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996011272A2 (en) * | 1994-10-07 | 1996-04-18 | Medigene Gesellschaft Für Molekularbiologische Diagnostik, Theraphie Und Technologie Mbh | Papilloma virus-like particles, fusion proteins and process for producing the same |
CU22871A1 (en) * | 1998-12-02 | 2003-10-21 | Ct Ingenieria Genetica Biotech | FORMULATIONS CONTAINING PARTICULARS SIMILAR TO VIRUS AS IMMUNOPOTENCERS BY MUCOSAL ROUTE |
AUPR011700A0 (en) * | 2000-09-14 | 2000-10-05 | Austin Research Institute, The | Composition comprising immunogenic virus sized particles (VSP) |
WO2003103570A2 (en) * | 2001-08-01 | 2003-12-18 | University Of Rochester | Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
CU23031A1 (en) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | SURFACE ANTIGEN OF THE HEPATITIS B VIRUS AS A MUCOSOPT IMMUNOPOTENTIATOR, RESULTS FORMULATIONS |
US9045727B2 (en) * | 2002-05-17 | 2015-06-02 | Emory University | Virus-like particles, methods of preparation, and immunogenic compositions |
WO2004042001A2 (en) * | 2002-05-17 | 2004-05-21 | Emory University | Virus-like particles, methods of preparation, and immonogenic compositions |
US7763259B2 (en) * | 2003-01-10 | 2010-07-27 | The Regents Of The University Of Colorado | Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
EP1790332B1 (en) | 2004-09-10 | 2010-07-21 | Asahi Glass Company, Limited | Human papilloma virus vaccine for oral administration |
US7691579B2 (en) | 2005-04-15 | 2010-04-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
US7445786B1 (en) | 2006-04-10 | 2008-11-04 | Manuela Rehtanz | Diagnosing and protecting against tursiops truncatus papillomavirus |
WO2008082719A2 (en) | 2006-08-30 | 2008-07-10 | University Of Rochester | Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
MX2012011340A (en) * | 2010-03-29 | 2012-11-16 | Novartis Ag | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant. |
AU2013209474B2 (en) * | 2012-01-20 | 2017-11-16 | South Dakota State University | Inulin and inulin acetate formulations |
EP4277654A1 (en) | 2021-01-18 | 2023-11-22 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020137A1 (en) * | 1993-03-09 | 1994-09-15 | University Of Rochester | Production of human papillomavirus capsid protein and virus-like particles |
WO1995031532A1 (en) * | 1994-05-16 | 1995-11-23 | Merck & Co., Inc. | Papillomavirus vaccines |
WO1996015247A1 (en) * | 1994-11-14 | 1996-05-23 | Merck & Co., Inc. | Purified papillomavirus proteins |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2170349B (en) * | 1985-01-25 | 1989-01-11 | Coal Ind | A method of treating an instrument having an electrode |
JP2648303B2 (en) * | 1985-04-04 | 1997-08-27 | ジョージタウン・ユニバーシティ | Type-specific papillomavirus DNA sequences and peptides |
US5071757A (en) * | 1986-10-06 | 1991-12-10 | Kreider John W | Methods for propagating fastidious human viruses and for producing purified suspensions thereof |
US5041385A (en) * | 1986-11-01 | 1991-08-20 | Oxford Gene Systems Limited | Vector expressing fusion proteins and particles |
US4870023A (en) * | 1987-03-16 | 1989-09-26 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
US4956288A (en) * | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5045447A (en) * | 1989-03-15 | 1991-09-03 | Minson Anthony C | Method of producing antibodies to HPV |
NZ232913A (en) * | 1989-03-15 | 1992-08-26 | Gist Brocades Nv | Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations |
WO1992010513A1 (en) * | 1990-12-12 | 1992-06-25 | The University Of Queensland | Subunit papillomavirus vaccine and peptides for use therein |
GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
US5169766A (en) * | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
AU651727B2 (en) * | 1991-07-19 | 1994-07-28 | Csl Limited | Papilloma virus vaccine |
US5346811A (en) * | 1991-07-22 | 1994-09-13 | Cerveceria Polar | Method and products for human papillomavirus detection |
DE122007000098I1 (en) * | 1992-06-25 | 2008-03-27 | PAPILLOMA VIRUS VACCINE | |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
WO1997002835A1 (en) * | 1995-07-07 | 1997-01-30 | Oravax, Inc. | Intranasal vaccination against gastrointestinal disease |
-
1998
- 1998-05-29 US US09/087,312 patent/US6153201A/en not_active Expired - Lifetime
-
1999
- 1999-05-27 CA CA 2329136 patent/CA2329136A1/en not_active Abandoned
- 1999-05-27 AU AU43162/99A patent/AU4316299A/en not_active Abandoned
- 1999-05-27 EP EP19990953290 patent/EP1079858A2/en not_active Withdrawn
- 1999-05-27 JP JP2000550511A patent/JP2002516291A/en active Pending
- 1999-05-27 WO PCT/US1999/011731 patent/WO1999061052A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020137A1 (en) * | 1993-03-09 | 1994-09-15 | University Of Rochester | Production of human papillomavirus capsid protein and virus-like particles |
WO1995031532A1 (en) * | 1994-05-16 | 1995-11-23 | Merck & Co., Inc. | Papillomavirus vaccines |
WO1996015247A1 (en) * | 1994-11-14 | 1996-05-23 | Merck & Co., Inc. | Purified papillomavirus proteins |
Non-Patent Citations (2)
Title |
---|
ROSE R C ET AL: "Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies", VACCINE,GB,BUTTERWORTH SCIENTIFIC. GUILDFORD, vol. 17, no. 17, 23 April 1999 (1999-04-23), pages 2129-2135, XP004164997, ISSN: 0264-410X * |
SCHILLER JT ET AL: "Papillomavirus-like particles and HPV vaccine development", SEMINARS IN CANCER BIOLOGY, vol. 7, 1996, pages 373 - 382, XP000857170 * |
Also Published As
Publication number | Publication date |
---|---|
AU4316299A (en) | 1999-12-13 |
JP2002516291A (en) | 2002-06-04 |
WO1999061052A2 (en) | 1999-12-02 |
US6153201A (en) | 2000-11-28 |
CA2329136A1 (en) | 1999-12-02 |
EP1079858A2 (en) | 2001-03-07 |
WO1999061052A9 (en) | 2000-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999061052A3 (en) | Oral immunization with papillomavirus virus-like particles | |
Christensen et al. | Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus | |
Pastrana et al. | Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2 | |
DE69835294T2 (en) | METHOD FOR THE VITRO DISPOSAL AND RE-COMPOSITION OF PAPILLOMA VIRUS LIKE PARTICLES (VLPS) | |
FR11C0022I2 (en) | HUMAN PAPILLOMA VIRUS CAPSID PROTEIN PRODUCTION AND VIRAL-LIKE PARTICLES | |
NO2018010I1 (en) | HPV 31 L1 protein | |
JP2005270111A (en) | Papilloma virus-like particles, fusion proteins and methods for their production | |
NL300313I1 (en) | Human papillomavirus vaccine | |
JP2010263899A (en) | Chimeric human papillomavirus 16l1 protein including l2 peptide, virus-like particle prepared therefrom, and method for preparing the particle | |
RU2007113184A (en) | ORAL VACCINE | |
SK4222002A3 (en) | Vaccine | |
CA2340422A1 (en) | Method for producing yeast expressed hpv types 6 and 16 capsid proteins | |
Frazer | HPV vaccines and the prevention of cervical cancer | |
CN101440371A (en) | 16 type human papilloma virus major capsid protein L1 gene | |
CN114127092B (en) | Human papillomavirus multivalent immunogenic compositions | |
De Carvalho | Cervical cancer vaccination: the real meaning of cross-protection and its impact on the prevention | |
Inglis | HPV Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/18-18/18, DRAWINGS, REPLACED BY NEW PAGES 1/18-18/18 |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 550511 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999953290 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999953290 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2329136 Country of ref document: CA |